Drug Pipeline

Fenebrutinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
1
Recruiting
3
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
3
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04586023 Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in… Relapsing Multiple Sclerosis Active, Not Recruiting
NCT04544449 A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in… Multiple Sclerosis, Primary Progressive Active, Not Recruiting
NCT04586010 A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide… Relapsing Multiple Sclerosis Active, Not Recruiting
Phase 2
NCT07161258 A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of… Relapsing Multiple Sclerosis Recruiting
NCT05119569 A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS) Relapsing Multiple Sclerosis Active, Not Recruiting
Sponsors Running Fenebrutinib Trials
Hoffmann-La Roche (5)
Disease Areas
Multiple Sclerosis (5)
Get alerts when Fenebrutinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free